Press release
April 26, 2016

Evonik’s special rings

Evonik Industries presents its product range of C8 chemicals. The specialty chemicals company is a leader in the production of industrially available cyclic C8 monomers and offers the four most important synthetic chemicals in this field 1,5-cyclooctadiene (COD), cyclooctene (COE), cyclooctane (COAN), and 4-vinylcyclohex-1-ene (VCH).

The C8 monomers are used for production of flame retardants, as modulators in polyolefin production, as building blocks in the perfume and aroma industries, and as intermediates for synthesis of specialty chemicals. 1,5-cyclooctadiene, for example, is used as a base material for producing effective flame retardants for plastics. COD and COE are also building blocks in the fragrance industry for production of components with musky base notes.

For more than 50 years Evonik’s High Performance Polymers Business Line has been offering, in addition to high-performance polymers and sheet products, the world’s widest range of industrially available cyclic C8 and C12 synthetic chemicals.

Further information is available at

About Resource Efficiency

The Resource Efficiency segment is led by Evonik Resource Efficiency GmbH and supplies high performance materials for environmentally friendly as well as energy-efficient systems to the automotive, paints & coatings, adhesives, construction, and many other industries. This segment employed about 8,600 employees, and generated sales of around €4.3 billion in 2015.

About Evonik

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.